Crossmark

Estimates of the Health and Economic Burden of Pneumococcal Infections Attributable to the 15-Valent Pneumococcal Conjugate Vaccine Serotypes in the USA

Crossref DOI link: https://doi.org/10.1007/s40121-022-00588-x

Published Online: 2022-01-27

Published Print: 2022-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Owusu-Edusei, Kwame

Deb, Arijita

Johnson, Kelly D.
Funding

Funding for this research was provided by:

Merck Sharp and Dohme
License Information

Text and Data Mining valid from 2022-01-27

Version of Record valid from 2022-01-27
More Information

Article History

Received: 17 November 2021

Accepted: 5 January 2022

First Online: 27 January 2022

Change Date: 6 March 2022

Change Type: Correction

Change Details: A Correction to this paper has been published:

Change Details: https://doi.org/10.1007/s40121-022-00613-z

Updates are available Correction dated 2022-03-06

Click to view Correction: https://doi.org/10.1007/s40121-022-00613-z